Standardized diagnostic evaluation based on hormone receptors (ER and PR) and HER-2 was essential to determine these subtypes and the histochemical staining of proliferation marker protein Ki-67 (MKI67) could be used to differentiate intracavity A-like and B-like breast cancer [35]. This evidence concerns the gene MKI67 and breast cancer.